U.S. to Treat Americans with Ebola in European Hospitals Instead of Domestic Facilities
Administration officials said on May 28, 2026 that infected Americans will instead be sent to European facilities still being identified by the CDC and State Department.
upi.comAdministration officials confirmed on May 28, 2026 that any Americans who contract Ebola will not be brought to the United States for treatment. They will instead be evacuated to as-yet-undetermined locations in Europe. The Centers for Disease Control and Prevention and the State Department are working to identify tertiary care facilities in Europe that could take Americans needing Ebola care.
One such case has already occurred. The policy applies to the current Ebola outbreak in the Democratic Republic of Congo and Uganda. S. is providing financial and other assistance in the response.
Craig Spencer contracted Ebola while working in Guinea during the West African outbreak in 2014. He developed symptoms after returning to the United States and was treated at New York’s Bellevue Hospital. Spencer is an emergency medicine physician and an associate professor in Brown University’s School of Public Health.
He credits the treatment he received at Bellevue for his survival. S. for care or quarantine.
The article was written by Helen Branswell, Infectious Diseases Correspondent at STAT, and published on May 28, 2026.
Transparency
Reported by a single outlet. This score reflects source tier and factual specificity — corroboration is limited with one source.
Story details
Related Stories
jpost.comEbola Cases in Central Africa Rise from 256 to About 1,000 in Eleven Days
Suspected and confirmed Ebola cases in the Democratic Republic of the Congo and Uganda increased from 256 on 16 May to roughly 1,000 by 27 May. The World Health Organization reported about 240 deaths during the same period.
medpagetoday.comFDA Panel Recommends XFG Variant for Fall Covid Shots
Replimune will submit an application to the FDA for the third time. Pfizer and Innovent Biologics reached a collaboration agreement valued at up to $10.5 billion.